Alterations in cytokine levels, particularly IL-1β, IL-6, IL-8, IL-10, transforming growth factor (TGF), and vascular endothelial growth factor (VEGF), which have either pro-inflammatory or immunosuppressive effects, have been described as potential biomarkers, as they promote a favourable environment for the development and progression of pancreatic diseases [13]. This evidence concerns the gene VEGFA and pancreas disorder.